Figures in the Special Focus Profiles

Data represented in many of the figures below can be downloaded at:  https://www.cdc.gov/std/stats17/figures/figureData.zip Cdc-zip[ZIP – 529 KB]

STDs in Women and Infants

Figure A. Pelvic Inflammatory Disease — Initial Visits to Physicians’ Offices Among Women Aged 15–44 Years, United States, 2007–2016

Figure B. Trends in the Percentage of Acute Pelvic Inflammatory Disease (PID) Emergency Department (ED) Visits Among Women Aged 15–44 Years by Age Group, United States, 2006–2013

Figure C. Pelvic Inflammatory Disease — National Estimates of Lifetime Prevalence Among Sexually Experienced Women Aged 18–44 Years by Race, Hispanic Ethnicity, and Previous STI Diagnosis, National Health and Nutrition Examination Survey (NHANES), 2013–2014

Figure D. Ectopic Pregnancy — Ratio Among Commercially Insured Women with Live Births Aged 15–44 Years by Age Group, 2005–2016

Figure E. Chlamydia — Rates of Reported Cases Among Women by State, United States and Outlying Areas, 2017

Figure F. Gonorrhea — Rates of Reported Cases Among Women by State, United States and Outlying Areas, 2017

Figure G. Chlamydia — Positivity Among Women Aged 14–39 Years by Race, Hispanic Ethnicity, and Age Group in Clinics Providing Family Planning and Reproductive Health Services, STD Surveillance Network (SSuN), 2017

Figure H. Chlamydia and Gonorrhea — Rates of Reported Cases Among Infants <1 Year of Age by Year and Specimen Source, United States, 2013–2017

Figure I. Primary and Secondary Syphilis — Rates of Reported Cases Among Women by State, United States and Outlying Areas, 2017

Figure J. Congenital Syphilis — Rates of Reported Cases Among Infants by Year of Birth and State, United States and Outlying Areas, 2017

STDs in Adolescents and Young Adults

Figure K. Chlamydia — Rates of Reported Cases Among Women Aged 15–24 Years by State, United States and Outlying Areas, 2017

Figure L. Chlamydia — Rates of Reported Cases Among Men Aged 15–24 Years by State, United States and Outlying Areas, 2017

Figure M. Gonorrhea — Rates of Reported Cases Among Women Aged 15–24 Years by State, United States and Outlying Areas, 2017

Figure N. Gonorrhea — Rates of Reported Cases Among Men Aged 15–24 Years by State, United States and Outlying Areas, 2017

Figure O. Chlamydia — Prevalence Among Women Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2017

Figure P. Chlamydia — Prevalence Among Men Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2017

Figure Q. Gonorrhea — Prevalence Among Women Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2017

Figure R. Gonorrhea — Prevalence Among Men Aged 16–24 Years Entering the National Job Training Program (NJTP) by State of Residence, United States and Outlying Areas, 2017

STDs in Racial and Ethnic Minorities

Figure S. Chlamydia — Rates of Reported Cases by Race, Hispanic Ethnicity, and Sex, United States, 2017

Figure T. Chlamydia — Rate Ratios Among Women Aged 15–24 Years by Race, Hispanic Ethnicity, and Region, United States, 2017

Figure U. Gonorrhea — Rates of Reported Cases by Race, Hispanic Ethnicity and Sex, United States, 2017

Figure V. Gonorrhea — Rate Ratios by Race, Hispanic Ethnicity, and Region, United States, 2017

Figure W. Primary and Secondary Syphilis — Reported Cases by Sex, Sexual Behavior, Race, and Hispanic Ethnicity, United States, 2017

Figure X. Primary and Secondary Syphilis — Rates of Reported Cases by Race, Hispanic Ethnicity, and Sex, United States, 2017

Figure Y. Primary and Secondary Syphilis — Rate Ratios by Sex, Race, Hispanic Ethnicity, and Region, United States, 2017

Figure Z. Congenital Syphilis — Rates of Reported Cases by Year of Birth, Race, and Hispanic Ethnicity of Mother, United States, 2008–2017

STDs in Men who Have Sex with Men

Figure AA. Primary and Secondary Syphilis — Estimated Rates of Reported Cases Among MSM by State, United States, 2017

Figure BB. Neisseria gonorrhoeae — Percentage of Urethral Isolates Obtained from MSM Attending STD Clinics, Gonococcal Isolate Surveillance Project (GISP), 1989–2017

Figure CC. Neisseria gonorrhoeae — Percentage of Urethral Isolates with Elevated Azithromycin Minimum Inhibitory Concentrations (MICs) (≥2.0 µg/ml) and Elevated Ceftriaxone MICs (≥0.125 μg/ml) by Reported Sex of Sex Partners, Gonococcal Isolate Surveillance Project (GISP), 2008–2017

Figure DD. Gonorrhea and Chlamydia — Proportion of MSM Attending STD Clinics Testing Positive for Urogenital Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2017

Figure EE. Gonorrhea and Chlamydia — Proportion of MSM Attending STD Clinics Testing Positive for Rectal Gonorrhea and Chlamydia by Jurisdiction, STD Surveillance Network (SSuN), 2017

Figure FF. Gonorrhea — Proportion of MSM Attending STD Clinics Testing Positive for Oropharyngeal Gonorrhea by Jurisdiction, STD Surveillance Network (SSuN), 2017

Figure GG. Proportion of MSM Attending STD Clinics with Primary and Secondary Syphilis, Urogenital Gonorrhea, or Urogenital Chlamydia by HIV Status, STD Surveillance Network (SSuN), 2017